Daily Care for October 14, 2020
advertisement
- ‘We have more to learn’: Data inconclusive on COVID-19 driving form of type 1 diabetes
- Antibody response in COVID-19 similar in adults with and without diabetes
- Emerging Data on Type 1 Diabetes and COVID-19 Reassuring
- Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe? (HTML)
- Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study (HTML)
- Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D
- Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA) (HTML)
- Depression Screening in Pediatric Type 1 Diabetes: Descriptive assessment of parental reactions to elevated depressive symptom scores (HTML)
- When Low Blood Sugars Cause High Anxiety: Fear of Hypoglycemia Among Parents of Youth With Type 1 Diabetes Mellitus (HTML)
- Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes? (HTML)
- Beyond Glycated Hemoglobin: Harnessing Data From Sensor-Based Technology to Improve Glucose Variability, Time in Range and Hypoglycemia in Adult Patients With Type 1 Diabetes (HTML)
- One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes (HTML)
- HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes (HTML)
- Revision of Alberta’s Provincial Insulin Pump Therapy Criteria for Adults and Children With Type 1 Diabetes: Process, Rationale and Framework for Evaluation (HTML)
- Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): evidence from the LMC Diabetes Registry (HTML)
- Worldwide differences in Childhood Type 1 Diabetes: The SWEET experience (HTML)
- Nurses’ and physicians’ experiences with diabetes consultations and the use of dialogue tools in the DiaPROM pilot trial: a qualitative study (HTML)
- Assessing disparities in barriers to attending pediatric diabetes camp (HTML)
- Defining features of diabetes resilience in emerging adults with type 1 diabetes (HTML)
- Impact of factory-calibrated Freestyle Libre System with new glucose algorithm measurement accuracy and clinical performance in children with type 1 diabetes during summer camp (HTML)
- Comparison of Analogue insulin with other insulins in patients with type 1 diabetes in Ahmedabad, Western India: A Rretrospective study (HTML)
- Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus (HTML)
- The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta‐analysis
